A new website is providing more details — including a new anchor tenant —for One Discovery Square, the roughly 90,000-square-foot biotech research, collaboration and innovation space under construction near Mayo Clinic in Rochester, Minn. Slated to open in April 2019, the four-story building is meant to be the first step in the creation of an innovation […]
Minnesota 2.0: Can this major U.S. medical device cluster become a healthcare innovation hub?
Minnesota has the institutions and the talent to transform healthcare in the U.S. The question is whether the money will follow. RxFunction makes wearable devices called “Walkasins” that help people with chronic health conditions prevent falls that can lead to serious injury. It took eight painstaking years, though, before the Eden Prairie, Minn.-based startup secured […]
Minnesota sees major medical device plant expansions
Medical device manufacturers are spending tens of millions of dollars on Minnesota plant expansions, but another heartening sign that the major device hub around the Minneapolis-St. Paul remains robust. LISI Medical Remmele—a maker of minimally invasive surgical devices, spinal implants, and drug infusion, urologic and vascular components—plans to nearly double the size of its Big Lake, […]
Medtech investment in Minnesota falls back to earth
After an off-the-charts year in investment for 2014, the Minnesota bioscience industry has seen a more typical 1st quarter, according to a report from medtech lobby LifeScience Alley.
Medtech investment hits 6-year high in Minnesota
Investment in Minnesota’s thriving medtech scene hit a 6-year high in 2014 and the state saw a significant jump in pharma/biotech investments, according to LifeScience Alley’s annual report.
Medtronic stock continues to hit new highs this month
Medtronic and Covidien prepare 1st Integration Summit
Diabetes: Medtronic study finds pumps beat injections for patient satisfaction
Insulin pumps beat manual injections for managing symptoms of Type 2 diabetes, according to the latest results from Medtronic’s (NYSE:MDT) OpT2mise clinical trials.
TCT 2014: Medtronic’s IN.PACT Admiral beats PTA in outcomes, costs
Treasury Secretary Lew nears decision on Medtronic’s Covidien inversion deal
Medtronic launches personalized heart rhythm therapy trial
- 1
- 2
- 3
- …
- 30
- Next Page »
MassDevice Network
@MassDevice
LinkedIn
Google+